Ann: Becoming a substantial holder, page-16

First 16 Last

Share
Profile

Follow
AlCp

26,811 Posts.

1737

22/09/17

17:33

Post #: 27403683
Share

Originally posted by TerribleTadpole ↑

I've said this several times before... the Australian studies weren't trials at all. They were studies designed to:
a) Gather symptoms and cough data for a bunch of patients, and the condition each patient was diagnosed with.
b) Train a classifier algorithm with the data and diagnoses.
c) Test the trained classifier (using leave-one-out) to measure the effectiveness of the training.

You can't use the training data to prove the training was effective. That's why we're initiating the new double-blind Australian trials.

I have a colleague at work who loves asking questions like, "what do we need to allow for that we haven't thought of?"

It seems like a stupid question. How can we think of what we haven't thought of?

But we can't possibly be the first company to ever try to collect sounds in a hospital or medical centre. Who else has attempted something like this? What snags did they hit? What did they do? Was there anything they luckily allowed for because it happened?

A quick search of ClinicalTrials.gov using cough sounds as the keywords turns up our study plus 12 others. Some can be ruled out as completely different: ultrasound images, neurological responses to sounds. But I can see 6 studies that can't be ruled out instantly. There might be more studies in archives or other medical resources. Perhaps some of those studies included sound recordings taken in hospitals. Perhaps some of those other organisations might be prepared to discuss issues they experienced or were able to predict with their trials.

If we could learn from other peoples' experiences it would be a whole lot better and cheaper than learning from our own mistakes!

PS: I hate working with the guy who asks about what we haven't thought of. He frustrates the heck out of me!

Expand

And that is why management were confident to do the clinical trials at the US with these Australian results......and from memory, RAP said these were complex FDA clinical trials (first ever????)

Last edited by AlCp: 22/09/17

RAP Price at posting: 7.0¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

IMM

Immutep reports strong response rate from immunotherapies treating carcinomas

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

NIM

Nimy to raise $1.21M to explore 'newsy' WA targets

I88

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

SKS

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

AII

Almonty locks in govt agreement for tungsten oxide plant in South Korea

MDI

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

BHP

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

ASX hits all time high out the gate on Friday trades following bullish US inflation data

Bitcoin investors need to know the risks

There are more pages in this discussion • 1 more message in this thread...

First 16 Last

Add RAP (ASX) to my watchlist

Ann: Becoming a substantial holder, page-16

Top Stories

Immutep reports strong response rate from immunotherapies treating carcinomas

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

Nimy to raise $1.21M to explore 'newsy' WA targets

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

Almonty locks in govt agreement for tungsten oxide plant in South Korea

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

ASX hits all time high out the gate on Friday trades following bullish US inflation data

Bitcoin investors need to know the risks

Featured News